Donor row firm recalls TB vaccine
Key points
- The pharmaceutical company at the centre of a Labour Party donation controversy is recalling all batches of its tuberculosis vaccine.
- The deal, which was done without public competition, was widely criticised in April because the head of the company, chief executive Paul Drayson, was a Labour Party donor.
- The company said it had consulted independent experts who had confirmed that the vaccine should still be effective but it was being "extra cautious".
- "At this stage there is no need to recall people for re-vaccination but the situation is being kept under review," he added.
The pharmaceutical company at the centre of a Labour Party donation controversy is recalling all batches of its tuberculosis vaccine.
A small numbers of the BCG formula did not meet end-of-shelf-life specifications, Powderject Pharmaceuticals Plc said.
The Department of Health welcomed the "prudent and responsible" course of action the company had taken and a spokesman said no concerns about the safety of the vaccine had been raised.
Powderject was awarded a Ј32m government contract to supply smallpox vaccine to protect 20 million Britons in the event of a germ warfare attack by terrorists.
Secret deal
The deal, which was done without public competition, was widely criticised in April because the head of the company, chief executive Paul Drayson, was a Labour Party donor.
And the company came under scrutiny again when a US report cast doubt on whether the UK had bought the right type of smallpox vaccine.
The problem with the BCG vaccine was initially identified in Ireland when a "small number" of batches approaching the end of their normal three-year shelf life were found to be "potentially less potent than normal".
Further testing identified a similar problem in a number of other batches at which point it was decided to order the recall.
School vaccine
The company said it had consulted independent experts who had confirmed that the vaccine should still be effective but it was being "extra cautious".
The Department of Health spokesman said the school vaccination programme would not be affected because it was not due to restart until October.
Sole supplier
"At this stage there is no need to recall people for re-vaccination but the situation is being kept under review," he added.
Currently no other BCG vaccine is licensed for use in the UK.
The government was forced to defend its links to the company, including the supply of BCG, when the smallpox deal was revealed.
Health minister Yvette Cooper said at the time: "Powderject was the only manufacturer with a UK licence to supply the BCG vaccine at that time."
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsStudy offers new way to discover HIV vaccine targets
Decades of research and three large-scale clinical trials have so far failed to yield an effective HIV vaccine, in large part because the virus evolves so rapidly that it can evade any vaccine-induced immune response.…
22 March 2013
NewsFlu vaccine less helpful for elderly than usual this year
It turns out this year's flu shot is doing a startlingly dismal job of protecting older people, the most vulnerable age group. The vaccine is proving only 9 percent effective in those 65 and older against the harsh…
25 February 2013
NewsFlu could be cured forever as vaccine might give life-long protection
A new flu vaccine being developed in Germany may be able to prevent the flu permanently through developing new cures more rapidly. Researchers at the Friedrich-Loeffler-Institut found that a vaccine based on the…
26 November 2012
